3 Things That Could Help 2023 Loser-Stock Moderna Roar Higher in 2024

Moderna (MRNA -1.77%) once was one of the stock market's biggest stars. The biotech stock surged more than 400% back in 2020 as it brought a coronavirus vaccine from drawing board to market in less than a year. And it continued to gain as it quickly generated billions of dollars in earnings, thanks to that vaccine.In recent times, though, Moderna's top-selling vaccine has prompted investors to turn away from the stock. That's because, as we head toward a post-pandemic situation, they're worrying about the c ...